COMMENTARY

• Open Innovation Bandwagon Gathers Pace for Efficient Drug Discovery
  January 26, 2015

• Have AGs Finally Become a Good Option to Counter Generics?
  January 19, 2015

• Will Legal Regulation Propel or Stymie Clinical Research? “Risk-Based” Approach Holds Key
  January 13, 2015

• Can Pharmas and Wholesalers Work to Dispel “Negative Primary Margins on Sales”?
  December 22, 2014

• April-Sept. Earnings Signal Watershed in Japan’s Shift to Generics
  December 15, 2014

• Wonder Drug? Savior? Avigan Clinical Trial for Ebola May Not Provide Clear-Cut Answer
  December 5, 2014

• Torii Eager to Carve Out New Market with Japan’s 1st Sublingual Allergen Immunotherapy
  November 25, 2014

• Was Weak Yen a Plus for April-Sept. Earnings? Profits Partly Canceled Out by Higher R&D, Import Costs
  November 18, 2014

• JPWA’s Uniform Tax Representation Will Benefit Wholesalers and Customers Alike
  November 10, 2014

• Can a More-Open ICH Maintain “Tri-Polar” Leadership? - Key Focus at Lisbon Meeting
  November 5, 2014

• Ex-Health Minister Tamura’s Clout Likely to Grow in Nagatacho
  October 14, 2014

• MHLW Has Trick Up Its Sleeve to Skirt 3 Straight Years of “Full-Scale” NHI Price Revisions
  October 6, 2014

• Revised PAL to Embrace “Deeper” Safety Measures, Yet Also Escape Clauses to Ease Company Burdens
  September 29, 2014

• Series of CRPC Drugs Make Japan Debut, Expanded Indications Key to Success
  September 24, 2014

• Picture of Future Regulations on Investigator-Led Clinical Research Emerging
  September 9, 2014

• With No Pilot at Helm, Pharma Industry Embroiled in Confusion with Voluntary Funding Disclosures
  September 1, 2014

• Wholesalers’ Q1 Earnings Remain Positive, Medical Fee Cut Rule Seen to Boost Accuracy of Financial Results in Sept.
  August 25, 2014

• Japanese Drug Makers Working to Increase Pace of Drug Discovery by Optimizing Operations at Research Centers
  August 18, 2014

• PMDA Sets Target Review Times for Partial Changes to Generic Approval - A New Way to Underpin Stable Supply
  August 4, 2014

• Competition Fuels Personalized Medicine Market, First-Line Positions Eyed for Xalkori, Alecensa
  July 28, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• …
• Next ›
• 最終 »